查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1541207

2024-2032 年按奈米分子類型、產品、應用和地區分類的奈米醫學市場報告

Nanomedicine Market Report by Nanomolecule Type, Product, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2023年全球奈米藥物市場規模達2,639億IMARC Group。

奈米醫學是指具有可編程特性的專門多功能藥物，用於在分子層面上治療疾病和修復組織。它涉及使用奈米顆粒、奈米管和奈米裝置（例如顯影劑、奈米機器人、生物晶片和聚合物療法）來診斷、治療和預防疾病，並分析潛在的病理生理學。奈米顆粒包括金屬和金屬氧化物、脂質體和無機顆粒，用於運輸藥物並靶向體內難以到達的區域。因此，奈米醫學在藥物傳輸、診斷影像、疫苗、再生醫學和植入物方面有著廣泛的應用。

奈米醫學市場趨勢：

全球慢性疾病盛行率的不斷上升是創造積極市場前景的關鍵因素之一。奈米醫學在治療腫瘤、神經、泌尿、感染、眼科、骨科、免疫和心血管疾病方面非常有益。與此一致的是，對個人化藥物的偏好的轉變也促進了市場的成長。此外，用於改進診斷程序的奈米級技術的各種技術進步也起到了其他生長誘導因素的作用。製藥商正在使用奈米機器人系統和其他新穎的解決方案來有效管理奈米藥物。其他因素，包括醫療保健基礎設施的改善，以及生物技術領域的廣泛研發（R&D）活動，預計將推動市場成長。

本報告回答的關鍵問題

  • 全球奈米醫藥市場有多大？ 2024-2032年全球奈米醫學市場的預期成長率是多少？
  • 推動全球奈米醫學市場的關鍵因素是什麼？
  • COVID-19 對全球奈米醫學市場有何影響？
  • 基於奈米分子類型的全球奈米藥物市場的詳細情形如何？
  • 基於該產品的全球奈米醫學市場的詳細情形如何？
  • 基於應用的全球奈米醫學市場的詳細情形如何？
  • 全球奈米醫藥市場的重點區域有哪些？
  • 全球奈米醫學市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球奈米醫學市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依奈米分子類型

  • 奈米粒子
    • 市場趨勢
    • 主要類型
      • 金屬和金屬氧化物奈米顆粒
      • 脂質體
      • 聚合物和聚合物藥物綴合物
      • 水凝膠奈米顆粒
      • 樹枝狀聚合物
      • 無機奈米粒子
    • 市場預測
  • 奈米殼
    • 市場趨勢
    • 市場預測
  • 奈米管
    • 市場趨勢
    • 市場預測
  • 奈米裝置
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：依產品

  • 療法
    • 市場趨勢
    • 市場預測
  • 再生醫學
    • 市場趨勢
    • 市場預測
  • 體外診斷
    • 市場趨勢
    • 市場預測
  • 體內診斷
    • 市場趨勢
    • 市場預測
  • 疫苗
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按應用

  • 臨床腫瘤學
    • 市場趨勢
    • 市場預測
  • 傳染病
    • 市場趨勢
    • 市場預測
  • 臨床心臟病學
    • 市場趨勢
    • 市場預測
  • 骨科
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Arrowhead Pharmaceuticals Inc.
    • General Electric Company
    • Luminex Corporation
    • Merck & Co. Inc.
    • Nanobiotix
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Starpharma Holdings Limited
Product Code: SR112024A4052

The global nanomedicine market size reached US$ 263.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 719.5 Billion by 2032, exhibiting a growth rate (CAGR) of 11.4% during 2024-2032.

Nanomedicine refers to specialized multi-functional drugs with programmable properties used for the treatment of diseases and repairing tissues at a molecular level. It involves the use of nanoparticles, nanotubes and nanodevices, such as imaging agents, nanorobots, biochips and polymer therapeutics, for the diagnosis, treatment and prevention of a disorder and analyzing the underlying pathophysiology. The nanoparticles include metal and metal oxides, liposomes and inorganic particles, which are used for transporting the drugs and targeting difficult to reach areas in the body. As a result, nanomedicine finds extensive applications for drug delivery, diagnostic imaging, vaccines, regenerative medicines and implants.

Nanomedicine Market Trends:

The increasing prevalence of chronic medical ailments across the globe is one of the key factors creating a positive outlook for the market. Nanomedicine is highly beneficial in the treatment of oncological, neurological, urological, infectious, ophthalmological, orthopedic, immunological and cardiovascular diseases. In line with this, shifting preference for personalized medicines is also contributing to the growth of the market. Additionally, various technological advancements in the nanoscale technologies for improved diagnostic procedures are acting as other growth-inducing factors. Pharmaceutical manufacturers are using nanorobotic systems and other novel solutions for the effective administration of nanomedicines. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biotechnology, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global nanomedicine market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on nanomolecule type, product and application.

Breakup by Nanomolecule Type:

Nanoparticles

Metal and Metal Oxide Nanoparticles

Liposomes

Polymers and Polymer Drug Conjugates

Hydrogel Nanoparticles

Dendrimers

Inorganic Nanoparticles

Nanoshells

Nanotubes

Nanodevices

Breakup by Product:

Therapeutics

Regenerative Medicine

In-Vitro Diagnostics

In-Vivo Diagnostics

Vaccines

Breakup by Application:

Clinical Oncology

Infectious Diseases

Clinical Cardiology

Orthopedics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arrowhead Pharmaceuticals Inc., General Electric Company, Luminex Corporation, Merck & Co. Inc., Nanobiotix, Novartis AG, Pfizer Inc., Sanofi SA and Starpharma Holdings Limited.

Key Questions Answered in This Report

  • 1. How big is the global nanomedicine market?
  • 2. What is the expected growth rate of the global nanomedicine market during 2024-2032?
  • 3. What are the key factors driving the global nanomedicine market?
  • 4. What has been the impact of COVID-19 on the global nanomedicine market?
  • 5. What is the breakup of the global nanomedicine market based on the nanomolecule type?
  • 6. What is the breakup of the global nanomedicine market based on the product?
  • 7. What is the breakup of the global nanomedicine market based on the application?
  • 8. What are the key regions in the global nanomedicine market?
  • 9. Who are the key players/companies in the global nanomedicine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nanomedicine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Nanomolecule Type

  • 6.1 Nanoparticles
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Metal and Metal Oxide Nanoparticles
      • 6.1.2.2 Liposomes
      • 6.1.2.3 Polymers and Polymer Drug Conjugates
      • 6.1.2.4 Hydrogel Nanoparticles
      • 6.1.2.5 Dendrimers
      • 6.1.2.6 Inorganic Nanoparticles
    • 6.1.3 Market Forecast
  • 6.2 Nanoshells
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Nanotubes
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Nanodevices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Therapeutics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Regenerative Medicine
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 In-Vitro Diagnostics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 In-Vivo Diagnostics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Vaccines
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Clinical Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Infectious Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinical Cardiology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Orthopedics
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Arrowhead Pharmaceuticals Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 General Electric Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Luminex Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Merck & Co. Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Nanobiotix
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Novartis AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sanofi SA
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Starpharma Holdings Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials

List of Figures

  • Figure 1: Global: Nanomedicine Market: Major Drivers and Challenges
  • Figure 2: Global: Nanomedicine Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Nanomedicine Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Nanomedicine Market: Breakup by Nanomolecule Type (in %), 2023
  • Figure 5: Global: Nanomedicine Market: Breakup by Product (in %), 2023
  • Figure 6: Global: Nanomedicine Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Nanomedicine Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Nanomedicine (Nanoparticles) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Nanomedicine (Nanoparticles) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Nanomedicine (Nanoshells) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Nanomedicine (Nanoshells) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Nanomedicine (Nanotubes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Nanomedicine (Nanotubes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Nanomedicine (Nanodevices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Nanomedicine (Nanodevices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Nanomedicine (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Nanomedicine (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Nanomedicine (Regenerative Medicine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Nanomedicine (Regenerative Medicine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Nanomedicine (In-Vitro Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Nanomedicine (In-Vitro Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Nanomedicine (In-Vivo Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Nanomedicine (In-Vivo Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Nanomedicine (Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Nanomedicine (Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Nanomedicine (Clinical Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Nanomedicine (Clinical Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Nanomedicine (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Nanomedicine (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Nanomedicine (Clinical Cardiology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Nanomedicine (Clinical Cardiology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Nanomedicine (Orthopedics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Nanomedicine (Orthopedics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Nanomedicine (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Nanomedicine (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: United States: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: United States: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Canada: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Canada: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Asia-Pacific: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Asia-Pacific: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: China: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: China: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Japan: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Japan: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: India: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: India: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: South Korea: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: South Korea: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Australia: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Australia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Indonesia: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Indonesia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Others: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Europe: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Europe: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Germany: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Germany: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: France: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: France: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United Kingdom: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United Kingdom: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Italy: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Italy: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Spain: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Spain: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Russia: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Russia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Middle East and Africa: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Middle East and Africa: Nanomedicine Market: Breakup by Country (in %), 2023
  • Figure 84: Middle East and Africa: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Global: Nanomedicine Industry: SWOT Analysis
  • Figure 86: Global: Nanomedicine Industry: Value Chain Analysis
  • Figure 87: Global: Nanomedicine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nanomedicine Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Nanomedicine Market Forecast: Breakup by Nanomolecule Type (in Million US$), 2024-2032
  • Table 3: Global: Nanomedicine Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: Nanomedicine Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Nanomedicine Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Nanomedicine Market: Competitive Structure
  • Table 7: Global: Nanomedicine Market: Key Players